frrol......Wrong it is not confirmation bias at all. It is the product of logical reasoning and math applied to the unique design of the Phase 2B trial. And my response was too daubersUP post that contained the following Statement from the company 10K:
"We monitor patient enrollment, the progress of clinical studies and
related activities to the extent possible through internal reviews of
data reported to us by the CROs, correspondence with the CROs and
clinical site visits."
This statement confirmed what i had thought the company was doing in regards to keeping current with what was being SEEN by those running the trial. Given the design of the trial and contact with the CROs and clinical site visits, it was possible to have a very good feel of the results of the trial even though it was blinded. It is a simple exercise in math to do so.
So i am awaiting word that you have used your very good intellect to understand what i have deduced months ago. And BTW i think it was a stroke of genius on the part of management to configure the design of the arms of the trial in this way. It is such pure genius that it had to be done on purpose.
News 
Market Data 
Discover 
